about us page title image

General Information

Byotrol plc (BYOT.L), quoted on AIM, develop and commercialise superior antimicrobial technologies, delivered via direct sales, alliances and in long-term partnerships with consumer and professional multi-nationals.

Our suite of technologies deliver powerful broad-spectrum, high-performance efficacy against commonly occurring and industry-specific pathogens.

Issued Share Capital

 Hargreaves Lansdown30,054,7966.98%
 Walker Crips25,077,0595.82%
 Amati Global Investors25,000,0015.80%
 Fidelity International25,000,0005.80%
 Tonex Holdings Limited15,251,5383.54%
 The Share Centre14,464,7563.36%
 Maven Capital Partners14,266,3123.31%
 ?What If! Holdings13,689,5693.18%
  • The company’s share: 0.25p each

  • Total issued shares capital: 430,885,271

  • Number of shares (if any) held in treasury: Nil

Pursuant to the AIM Rules, and insofar as the Company is aware, as at 05/12/18, 9.26% of the Company’s AIM securities were not in public hands.

There are no restrictions on the transfer of the ordinary shares in the capital of the company. The Company is subject to the UK City Code on Takeovers and Mergers.

The Investor Relations section of this website discloses all information as required by AIM rule 26.

Last updated 17th December 2018

Country of Incorporation

The company is incorporated in England and Wales and its main country of operation is currently the United Kingdom.

The company’s shares are only traded on AIM.

The Board recognises the importance of sound corporate governance and intends to ensure that the Company adopts policies and procedures which reflect such of the principles of the Corporate Governance Guidelines for AIM Companies published by the Quoted Companies Alliance, as are considered appropriate for the Company’s size.

Responsibilities of the Board and Committees

  1. Remuneration Committe
  2. Audit Committee


The Remuneration Committee

The Remuneration Committee is responsible for making recommendations to the Board on the Company’s framework of Executive remuneration and its cost.
The Committee determines the contract terms, remuneration and other benefits for each of the Executive Directors, including performance related bonus schemes, pension rights and compensation payments.

The Board itself determines the remuneration of the Non-Executive Directors. The Remuneration Committee comprises John Langlands, Chairman and Dr Till Medinger.


The Audit Committee

The Audit Committee comprises Dr Till Medinger and John Langlands, Chairman.

Its prime tasks are to review the scope of internal and external audit, to receive regular reports from Mazars LLP, and to review the half-yearly and annual accounts before they are presented to the Board, focusing in particular on accounting policies and areas of management judgment and estimation.

The committee is responsible for monitoring the controls which are in force to ensure the integrity of the information reported to the shareholders.

The committee acts as a forum for discussion of internal control issues and contributes to the Board’s review of the effectiveness of the Company’s internal control and risk management systems and processes.

The committee has considered the need for an internal audit function and has concluded that, at the present time, no such function is necessary.

This will be reviewed on a regular basis.

It advises the Board on the appointment of external auditors and on their remuneration for both audit and non-audit work, and discusses the nature and scope of the audit with the external auditors.

Regulatory Documents


The information contained in this website is only for general information purposes and to comply with AIM rule 26. The information is provided by Byotrol plc and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of Byotrol plc. We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, Byotrol plc takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

Website Disclaimer
Website Disclaimer

Byotrol Website disclaimer

Right Click and 'Save Link As...' to download